Best Vesicular Monoamine Transporter 2 Inhibitor for tardive dyskinesia
2 Vesicular Monoamine Transporter 2 Inhibitor drugs indicated for tardive dyskinesia, ranked by our independent rating. The current highest-rated is ingrezza. Compare them with all treatments for tardive dyskinesia or the full Vesicular Monoamine Transporter 2 Inhibitor class. Not medical advice — always consult a professional.
Top vesicular monoamine transporter 2 inhibitor for tardive dyskinesia: 1. Ingrezza · 2. Ingrezza Sprinkle
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Ingrezza | Not yet rated | Prescription | — | View → |
| 2 | Ingrezza Sprinkle | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
ingrezza
PrescriptionFDA-sourced
INGREZZA and INGREZZA SPRINKLE contains valbenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor, present as valbenazine tosylate salt.
vesicular monoamine transporter 2 inhibitortardive dyskinesia
Price varies
ingrezza sprinkle
Frequently asked
- What is the best vesicular monoamine transporter 2 inhibitor for tardive dyskinesia?
- By our independent rating, ingrezza currently ranks highest among Vesicular Monoamine Transporter 2 Inhibitor drugs used for tardive dyskinesia. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which vesicular monoamine transporter 2 inhibitor drugs treat tardive dyskinesia?
- pharmaranks lists 2 Vesicular Monoamine Transporter 2 Inhibitor products indicated for tardive dyskinesia, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.